Health Care & Life Sciences » Biotechnology | BELLUS Health Inc.

BELLUS Health Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
872.00
1,968.00
405.00
2,159.00
1,874.00
9,084
Other Funds
1,282.00
-
-
-
-
254
Funds from Operations
2,709.00
2,007.00
302.00
1,805.00
5,437.00
8,830
Changes in Working Capital
428.00
1,300.00
3,013.00
1,049.00
1,145.00
1,009
Net Operating Cash Flow
3,137.00
3,307.00
2,711.00
2,854.00
4,292.00
9,839
Capital Expenditures
-
-
-
-
1,334.00
Sale of Fixed Assets & Businesses
398.00
-
-
-
2,117.00
Purchase/Sale of Investments
4,649.00
5,989.00
3,249.00
2,404.00
10,111.00
Net Investing Cash Flow
4,959.00
6,077.00
3,249.00
2,404.00
9,328.00
Issuance/Reduction of Debt, Net
67.00
5,193.00
-
-
-
Net Financing Cash Flow
1,349.00
5,193.00
-
-
18,831.00
Net Change in Cash
534.00
2,386.00
5,854.00
464.00
5,174.00
Free Cash Flow
3,137.00
3,307.00
2,711.00
-
4,292.00
Deferred Taxes & Investment Tax Credit
-
49.00
27.00
15.00
61.00
-
Other Sources
-
88.00
-
-
-
Change in Capital Stock
-
-
-
-
18,831.00
Exchange Rate Effect
61.00
37.00
106.00
14.00
37.00
Other Uses
88.00
-
-
-
-

About BELLUS Health

View Profile
Address
275 Armand-Frappier boulevard
Laval Québec H7V 4A7
Canada
Employees -
Website http://www.bellushealth.com
Updated 07/08/2019
BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on April 12, 2012 and is headquartered in Laval, Canada.